Chapter 4729:3-3 Pharmacy Technician Trainees

4729:3-3-01 Pharmacy technician trainees.

(A) A pharmacy technician trainee shall wear a name tag or badge which contains the designation "Pharmacy Technician Trainee." The required designation may be added to an existing name tag or badge. The name tag or badge and the required designation shall contain lettering of a legible size.

(B) A pharmacy technician trainee may, under the direct supervision of a pharmacist, engage in the following activities at a location licensed as a terminal distributor of dangerous drugs to the extent that the activities do not require the exercise of professional judgment:

(1) Accepting new written, faxed or electronic prescription orders from a prescriber or a prescriber's agent but shall not include verbal orders;

(2) Entering information into and retrieving information from a database or patient profile;

(3) Preparing and affixing labels;

(4) Stocking dangerous drugs and retrieving those drugs from inventory;

(5) Counting and pouring dangerous drugs into containers;

(6) Placing dangerous drugs into containers prior to dispensing by a pharmacist;

(7) Non-sterile drug compounding following the completion of site-specific training pursuant to rule 4729:3-3-02 of the Administrative Code;

(8) Sterile drug compounding following the completion of a site-specific training pursuant to rule 4729:3-3-02 of the Administrative Code;

(9) Packaging and selling a dangerous drug to a patient or patient representative; and

(10) Sending or receiving electronic prescriptions between pharmacies accessing the same prescription records in a centralized database or pharmacy computers linked in any other manner.

(C) A pharmacist is not permitted to supervise more than three pharmacy technician trainees engaging in the activities pursuant to paragraph (B) of this rule at any time, unless otherwise approved by the board.

(D) The number of pharmacy technician trainees supervised by a pharmacist does not limit the number of pharmacy interns that can be supervised by a pharmacist in accordance with rule 4729:2-1-01 of the Administrative Code.

Effective: 11/20/2017
Five Year Review (FYR) Dates: 11/20/2022
Promulgated Under: 119.03
Statutory Authority: 4729.26, 4729.94
Rule Amplifies: 4729.90, 4729.96, 4729.95, 4729.94 , 4729.93, 4729.921, 4729.92 , 4729.91, 4729.901

4729:3-3-02 Approved pharmacy technician training programs.

The purpose of this rule is to set standards for pharmacy technician training programs to ensure that graduates of the programs have the basic knowledge and experience in general pharmacy to practice in most pharmacy settings.

(A) The state board of pharmacy hereby approves the following pharmacy technician training programs:

(1) A pharmacy technician training program that holds a current accreditation from the American society of health-system pharmacists/accreditation council for pharmacy education.

(2) A program of training for pharmaceutical technicians conducted by a branch of the Armed Forces of the United States, the Indian health service of the United States department of health and human services or the United States department of veterans affairs.

(3) An employer-based training program that meets the requirements in paragraph (B) of this rule.

(4) A pharmacy technician training program offered by an Ohio public high school as part of a career-technical education program approved by the Ohio department of education pursuant to section 3317.161 of the Revised Code. Each career-technical education program shall require approval by the state board of pharmacy in accordance with standards adopted by the board. Instructions for obtaining board approval will be made available on the board's website:www.pharmacy.ohio.gov.

(B) An employer-based training program shall comply with all the following:

(1) The program shall have a program director. The program director and the employer licensed as a terminal distributor of dangerous drugs shall be accountable for the overall quality of the employer-based training program.

The program director shall be a licensed pharmacist in this or any other state that is in good standing.

(2) The program shall consist of didactic and practical experience training, as follows:

(a) A didactic training component that includes, at a minimum, instruction in all of the following:

(i) Mathematical calculations essential to the duties of a pharmacy technician;

(ii) Federal and state laws, rules and regulations that affect pharmacy practice, including specific laws, rules and regulations which address the use of technicians;

(iii) Medical and pharmaceutical terminology, symbols and abbreviations used in the practice of pharmacy and components of a prescription;

(iv) Preparation, packaging, labeling and proper storage of dangerous drugs;

(v) Knowledge and skills in areas of science relevant to the pharmacy technician's role, including pharmacology;

(vi) Medication safety and error prevention;

(vii) Maintaining confidentiality of patient information, including the Patient Rights and Health Insurance Portability and Accountability Act (HIPAA);

(viii) Ethical and professional standards of practice;

(ix) Recordkeeping and inventory control; and

(x) Patient and caregiver communication, including communicating with diverse populations.

(b) Didactic training may include self-directed learning experiences, including but not limited to home study, computer programs, internet or web-based courses, or any other coursework approved by the program director.

(c) The program shall ensure the required didactic training evaluates a participant's knowledge of the topics listed in paragraph (B)(2)(a) of this rule. The evaluation must include an examination consisting of a minimum of ninety questions in accordance with testing guidelines adopted by the board. The employer shall have procedures that ensure the security and integrity of the examination materials, describe the testing format, and define the successful completion of an examination, which must be at least seventy-five per cent. The examination shall consist primarily of multiple choice, essay, or short answer questions. The questions on the examination shall not be given to the examinee prior to taking the examination. The answers to the examination must not be given to the examinee prior to or during the examination. The examinee shall agree in writing not to share the questions or answers to the examination with any other person.

(d) The didactic training requirements in paragraph (B)(2)(a) of this rule are waived if the trainee has a current pharmacy technician certification from an organization that has been recognized by the board.

(e) Three hundred hours of practical experience in a pharmacy under the direct supervision of a licensed pharmacist that directly relates to the activities permitted in paragraph (B) of rule 4729:3-3-01 of the Administrative Code.

(3) A written or electronic record of training and education shall be maintained as part of the training program that documents the completion of the training requirements, including the number of practical experience hours completed. This documentation must include an attestation by the program director and the terminal distributor's responsible person where the technician is employed that the technician trainee has successfully completed the training program and certifies the competency of each technician trainee completing the training program pursuant to this rule. A copy of the documentation shall be provided to each participant who successfully completes the program.

(4) The program director must ensure that regular and ongoing assessments of program effectiveness are conducted and use the evaluations for continuous improvement of the program. Measures shall include, but are not limited to, the following:

(a) Program completion; and

(b) Program participant satisfaction.

(5) The program shall maintain the following records for a minimum of three years and shall be furnished to the state board of pharmacy within three business days of receipt of a request from the board:

(a) All technician training records and evaluations;

(b) Program assessments conducted in accordance with this rule.

(6) Employer-based training programs may be subject to audit to ensure compliance with the requirements of this rule.

(a) An employer-based training program subject to audit shall provide all requested documentation demonstrating compliance with this rule within thirty days of a request by the board.

(b) Unless an extension is granted, failure to provide the requested documentation within thirty days of a request by the board may result in the suspension of the approval status of the training program.

(c) After reviewing the training program, the board may return it to the employer for revision. Failure to make the necessary revisions may result in the suspension of the approval status of the training program.

(d) The approval status of a training program may be reinstated only after the employer meets the requirements of this rule and any additional requirements as determined by the board.

(C) In order to perform non-sterile drug compounding, a pharmacy technician trainee shall complete the following training requirements prior to compounding non-sterile preparations:

(1) Training shall comply with the requirements set forth in the United States pharmacopeia chapter <795>.

(2) Non-sterile drug compounding training shall be obtained through completion of a site-specific, structured on-the-job didactic and experiential training program and shall not be transferable to another practice site, except between practice sites under common ownership and control.

(3) When the responsible person or a pharmacist designated by the responsible person is satisfied with the employee's knowledge and proficiency, the responsible person or the responsible person's designee will sign the documentation records to show that the employee was appropriately trained in accordance with this paragraph.

(4) Ensuring pharmacy technician trainees are properly trained shall be the responsibility of the terminal distributor of dangerous drugs and the licensee's responsible person.

(5) All training requirements set forth in this paragraph shall be appropriately documented and made readily retrievable for immediate inspection by an agent of the state board of pharmacy. Documentation shall be maintained by the terminal distributor of dangerous drugs for a minimum of three years.

(6) The training required pursuant to this paragraph may be used to meet the practical experience hours required in paragraph (B)(2)(e) of this rule.

(D) In order to perform sterile drug compounding, a pharmacy technician trainee shall complete the following training requirements prior to compounding sterile preparations:

(1) Training shall comply with the requirements set forth in the United States pharmacopeia chapter <797>.

(2) Sterile drug compounding training shall be obtained through completion of a site- specific, structured on-the-job didactic and experiential training program and shall not be transferable to another practice site, except between practice sites under common ownership and control.

(3) When the responsible person or a pharmacist designated by the responsible person is satisfied with the employee's knowledge and proficiency, the responsible person or the responsible person's designee will sign the documentation records to show that the employee was appropriately trained in accordance with this paragraph.

(4) Ensuring pharmacy technician trainees are properly trained shall be the responsibility of the terminal distributor of dangerous drugs and the licensee's responsible person.

(5) All training requirements set forth in this paragraph shall be appropriately documented and made readily retrievable for immediate inspection by an agent of the state board of pharmacy. Documentation shall be maintained by the terminal distributor of dangerous drugs for a minimum of three years.

(6) The training required pursuant to this paragraph may be used to meet the practical experience hours required in paragraph (B)(2)(e) of this rule.

(E) A terminal distributor of dangerous drugs and the licensee's responsible person shall be responsible for the implementation of additional training that is of appropriate breadth and depth to clearly address the competencies for a technician trainee to safely and effectively work in a specific practice setting.

(F) Unless otherwise approved by the board, a board approved training program is only valid for application as a registered pharmacy technician or certified pharmacy technician in accordance with rule 4729:3-2-01 of the Administrative Code if the program was completed within five years of an application for registration.

(G) Paragraph (F) of this rule does not apply in the following circumstances:

(1) An applicant for registration has been actively practicing as a pharmacy technician in this or another state within one year of application to the board; or

(2) An applicant has maintained a current pharmacy technician certification from an organization that has been recognized by the board.

(H) An individual may sit for an examination to obtain a pharmacy technician certification from an organization that has been recognized by the board at any time.

Effective: 2/16/2018
Five Year Review (FYR) Dates: 02/16/2023
Promulgated Under: 119.03
Statutory Authority: 4729.26, 4729.94
Rule Amplifies: 4729.90, 4729.96, 4729.95, 4729.94 , 4729.93, 4729.921, 4729.92 , 4729.91, 4729.901

4729:3-3-03 Registered pharmacy technicians.

(A) A registered pharmacy technician shall wear a name tag or badge which contains the designation "Registered Pharmacy Technician." The required designation may be added to an existing name tag or badge. The name tag or badge and the required designation shall contain lettering of a legible size.

(B) A registered pharmacy technician may, under the direct supervision of a pharmacist, engage in the following activities at a location licensed as a terminal distributor of dangerous drugs to the extent that the activities do not require the exercise of professional judgment:

(1) Accepting new written, faxed or electronic prescription orders from a prescriber or a prescriber's agent but shall not include verbal orders;

(2) Requesting refill authorizations for dangerous drugs from a prescriber or prescriber's agent, so long as there is no change from the original prescription;

(3) Entering information into and retrieving information from a database or patient profile;

(4) Preparing and affixing labels;

(5) Stocking dangerous drugs and retrieving those drugs from inventory;

(6) Counting and pouring dangerous drugs into containers;

(7) Placing dangerous drugs into containers prior to dispensing by a pharmacist;

(8) Non-sterile drug compounding in accordance with the required training in paragraph (C) of this rule;

(9) Packaging and selling a dangerous drug to a patient or patient representative; and

(10) Sending or receiving electronic prescriptions between pharmacies accessing the same prescription records in a centralized database or pharmacy computers linked in any other manner.

(C) In order to perform non-sterile drug compounding, a registered pharmacy technician shall complete the following training requirements prior to compounding non-sterile preparations:

(1) Training shall comply with the requirements set forth in the United States pharmacopeia chapter <795>.

(2) Non-sterile drug compounding training shall be obtained through completion of a site-specific, structured on-the-job didactic and experiential training program and shall not be transferable to another practice site, except between practice sites under common ownership and control.

(3) When the responsible person or a pharmacist designated by the responsible person is satisfied with the employee's knowledge and proficiency, the responsible person or the responsible person's designee will sign the documentation records to show that the employee was appropriately trained in accordance with this rule.

(4) Ensuring registered pharmacy technicians are properly trained shall be the responsibility of the terminal distributor of dangerous drugs and the licensee's responsible person.

(5) All training requirements set forth in this paragraph shall be appropriately documented and made readily retrievable for immediate inspection by an agent of the state board of pharmacy. Documentation shall be maintained by the terminal distributor of dangerous drugs for a minimum of three years.

(D) A terminal distributor of dangerous drugs and the licensee's responsible person shall be responsible for the implementation of policies and procedures for additional training appropriate to duties and responsibilities performed by a registered pharmacy technician as well as an ongoing quality assurance plan to ensure competency.

Effective: 12/4/2017
Five Year Review (FYR) Dates: 12/04/2017
Promulgated Under: 119.03
Statutory Authority: 4729.26, 4729.94
Rule Amplifies: 4729.90, 4729.96, 4729.95, 4729.94 , 4729.93, 4729.921, 4729.92 , 4729.91, 4729.901

4729:3-3-04 Certified pharmacy technicians.

(A) A certified pharmacy technician shall wear a name tag or badge which contains the designation "Certified Pharmacy Technician." The required designation may be added to an existing name tag or badge. The name tag or badge and the required designation shall contain lettering of a legible size.

(B) A certified pharmacy technician may, under the direct supervision of a pharmacist, engage in the following activities at a location licensed as a terminal distributor of dangerous drugs to the extent that the activities do not require the exercise of professional judgment:

(1) Accepting new written, faxed or electronic prescription orders from a prescriber or a prescriber's agent. New verbal prescription orders from a prescriber or a prescriber's agent for non-controlled drugs may be accepted pursuant to paragraph (B)(14) of this rule.

(2) Entering information into and retrieving information from a database or patient profile.

(3) Preparing and affixing labels.

(4) Stocking dangerous drugs and retrieving those drugs from inventory.

(5) Counting and pouring dangerous drugs into containers.

(6) Placing dangerous drugs into containers prior to dispensing by a pharmacist.

(7) Non-sterile drug compounding in accordance with the required training in paragraph (C) of this rule.

(8) Sterile drug compounding in accordance with the required training in paragraph (D) of this rule.

(9) Packaging and selling a dangerous drug to a patient or patient representative.

(10) Sending or receiving electronic prescriptions between pharmacies accessing the same prescription records in a centralized database or pharmacy computers linked in any other manner.

(11) Within an institutional facility as defined in agency 4729 of the Administrative Code, stocking automated drug dispensing units, floor stock and crash carts.

(12) Accepting verbal refill authorizations for dangerous drugs that are not controlled substances from a prescriber or the prescriber's agent, so long as there is no change from the original prescription.

(13) Requesting refill authorizations for dangerous drugs from a prescriber or prescriber's agent, so long as there is no change from the original prescription;

(14) Notwithstanding any other provision of agency 4729 of the Administrative Code, accepting new verbal prescription orders for non-controlled drugs from a prescriber or a prescriber's agent pursuant to the following:

(a) The pharmacist on duty who is supervising the activity of the certified pharmacy technician will determine if the technician is competent to receive a verbal order.

(b) The pharmacist on duty who is supervising the activity of the certified pharmacy technician is responsible for the accuracy of a prescription order received by a technician.

(c) The pharmacist on duty must be immediately available to answer questions or discuss the prescription order received by a certified pharmacy technician.

(d) The certified pharmacy technician may not receive a prescription order for a controlled substance.

(e) If applicable, the certified pharmacy technician receiving a prescription order must document the full name of the prescriber's agent.

(f) The receiving certified pharmacy technician shall immediately reduce the prescription order to writing and shall review the prescription with the pharmacist on duty.

(g) Prior to dispensing, positive identification of the receiving certified pharmacy technician and the pharmacist on duty shall be made on the prescription to identify the responsibility for the receipt of the prescription.

(h) The certified pharmacy technician and the pharmacist on duty must meet all other applicable rules for the receipt of new verbal prescription orders pursuant to agency 4729 of the Administrative Code.

(15) Send or receive copies of non-controlled prescriptions pursuant to the following:

(a) The pharmacist on duty who is supervising the activity of the certified pharmacy technician will determine if the technician is competent to send or receive a prescription copy.

(b) The pharmacist on duty who is supervising the activity of the certified pharmacy technician is responsible for the accuracy of a prescription copy that is sent or received by a technician.

(c) The pharmacist on duty must be immediately available to answer questions or discuss the prescription copy that is sent or received by a certified pharmacy technician.

(d) The certified pharmacy technician may not send or receive a prescription copy for a controlled substance.

(e) The pharmacist or certified pharmacy technician receiving a prescription copy from a certified pharmacy technician must document the full names of the sending technician and the technician's supervising pharmacist. The receiving technician shall immediately reduce the prescription copy to writing and shall review the prescription with the pharmacist on duty. Prior to dispensing, positive identification of the certified pharmacy technician and the pharmacist on duty shall be made on the prescription to identify the responsibility for the receipt of the copy.

(f) The pharmacist or certified pharmacy technician sending a prescription copy to a certified technician must document the full names of the receiving technician and the technician's supervising pharmacist. There must be documented positive identification of the sending certified pharmacy technician and the pharmacist on duty who authorized the transfer of the prescription copy.

(g) The certified technician and the pharmacist on duty must meet all other applicable rules for the transfer of a prescription copy pursuant agency 4729 of the Administrative Code.

(16) Contacting a prescriber or prescriber's agent to obtain clarification for a prescription order if the clarification does not require the exercise of professional judgment.

(C) In order to perform non-sterile drug compounding, a certified pharmacy technician shall complete the following training requirements prior to compounding non-sterile preparations:

(1) Training shall comply with the requirements set forth in the United States pharmacopeia chapter <795>.

(2) Non-sterile drug compounding training shall be obtained through completion of a site-specific, structured on-the-job didactic and experiential training program and shall not be transferable to another practice site, except between practice sites under common ownership and control.

(3) When the responsible person or a pharmacist designated by the responsible person is satisfied with the employee's knowledge and proficiency, the responsible person or the responsible person's designee will sign the documentation records to show that the employee was appropriately trained in accordance with this rule.

(4) Ensuring certified pharmacy technicians are properly trained shall be the responsibility of the terminal distributor of dangerous drugs and the licensee's responsible person.

(5) All training requirements set forth in this paragraph shall be appropriately documented and made readily retrievable for immediate inspection by an agent of the state board of pharmacy. Documentation shall be maintained by the terminal distributor of dangerous drugs for a minimum of three years.

(D) In order to perform sterile drug compounding, a certified pharmacy technician shall complete the following training requirements prior to compounding sterile preparations:

(1) Training shall comply with the requirements set forth in the United States pharmacopeia chapter <797>.

(2) Sterile drug compounding training shall be obtained through completion of a site- specific, structured on-the-job didactic and experiential training program and shall not be transferable to another practice site, except between practice sites under common ownership and control.

(3) When the responsible person or a pharmacist designated by the responsible person is satisfied with the employee's knowledge and proficiency, the responsible person or the responsible person's designee will sign the documentation records to show that the employee was appropriately trained in accordance with this rule.

(4) Ensuring certified pharmacy technicians are properly trained shall be the responsibility of the terminal distributor of dangerous drugs and the licensee's responsible person.

(5) All training requirements set forth in this paragraph shall be appropriately documented and made readily retrievable for immediate inspection by an agent of the state board of pharmacy. Documentation shall be maintained by the terminal distributor of dangerous drugs for a minimum of three years.

(E) A terminal distributor of dangerous drugs and the licensee's responsible person shall be responsible for the implementation of policies and procedures for additional training appropriate to duties and responsibilities performed by a certified pharmacy technician as well as an ongoing quality assurance plan to ensure competency.

Effective: 12/4/2017
Five Year Review (FYR) Dates: 12/04/2017
Promulgated Under: 119.03
Statutory Authority: 4729.26, 4729.94
Rule Amplifies: 4729.90, 4729.96, 4729.95, 4729.94 , 4729.93, 4729.921, 4729.92 , 4729.91, 4729.901